Intrinsic Value of S&P & Nasdaq Contact Us

Valneva SE VALN NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • FR • USD

SharesGrow Score
44/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$18.33
+201%

Stock Statistics — VALN

Valneva SE (VALN) has a market capitalization of $524.01M and trades at $6.09. The 52-week range is 5.429-12.25.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -4.6, Earnings Per Share (EPS) of $-1.32, annual revenue of $174.66M.

The stock has a beta of 1.53, operates in the Healthcare sector.

Trading Data
Current Price$6.09
52-Week Range5.429-12.25
Volume91.16K
Avg Volume (30D)64.21K
Market Cap$524.01M
Beta (1Y)1.53
Company
IPO Date2021-05-05
Employees713
CEOThomas Lingelbach
CountryFR
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS92025Y1038
CUSIP92025Y103
Income (Latest Year)
Revenue$174.66M
Gross Profit$67.52M
EBITDA$-50.47M
Operating Income$-81.63M
Net Income$-115.19M
EPS$-1.32
EPS Diluted$-1.32
Shares Outstanding$84.09M
Balance Sheet (Latest Year)
Total Assets$398.84M
Current Assets$222.54M
Cash & ST Investments$109.65M
Total Liabilities$292.67M
Total Debt$207.25M
Net Debt$97.6M
Total Equity$106.17M
Debt / Equity1.95
Valuation Ratios
P/E Ratio-4.6
P/S Ratio3
P/B Ratio4.94
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message